U.S. Transportation Stock News

FactSet Research Systems (NYSE:FDS) has partnered with Kepler Cheuvreux to add premium sell side equity research to its platform. The agreement expands research coverage across Europe and the wider EMEA region for institutional clients using FactSet. The collaboration uses AI tools to deliver Kepler Cheuvreux Aftermarket Research content within FactSet’s existing workflows. FactSet, a long standing data and analytics provider for institutional investors, is broadening its content set with...

Lam Research opened a new office in Boise, Idaho, to work more closely with Micron Technology on research and high volume manufacturing. The move is aimed at supporting memory manufacturing tied to AI focused semiconductor demand. For investors watching Lam Research, NasdaqGS:LRCX, this update comes with a current share price of $240.09. The stock shows very large 3 year gains and a strong 1 year move of 176.4%. Year to date it is up 29.7%, and 7.7% over the past 30 days. A 2.1% gain over...

Booking Holdings Inc. has released its fourth-quarter and full-year 2025 results, reporting revenue of US$6,349 million and net income of US$1,428 million for the quarter, and full-year revenue of US$26.92 billion with net income of US$5.40 billion, alongside higher quarterly earnings per share but lower full-year earnings per share versus 2024. The earnings beat on adjusted fourth-quarter profit and revenue, helped by increased room nights and bookings, highlights the impact of Booking’s...

National HealthCare (NHC) has just expanded its board from seven to nine directors, adding geriatric medicine leader Dr. David Gifford and long-term care operator and business executive Andrew Adams. The move is aimed at deepening clinical and operational oversight. See our latest analysis for National HealthCare. Those board additions come as National HealthCare’s share price sits at US$162.10 following a 1-day share price return of a 1.7% decline and a 7-day share price return of a 3.7%...

Carvana, NYSE:CVNA, is facing accounting fraud allegations tied to claims of earnings overstatement and undisclosed related party transactions. The company is under an active SEC investigation while questions build around substantial insider selling activity. These issues are emerging as Carvana reports record vehicle sales and strong revenue, but with pressured margins and elevated operating costs. For investors watching NYSE:CVNA, the backdrop is complicated. The stock trades at $361.53,...

If you are wondering whether HA Sustainable Infrastructure Capital's current share price lines up with its underlying worth, this article is designed to walk you through that question clearly and calmly. The stock most recently closed at US$37.77, with returns of 1.5% over 7 days, 9.6% over 30 days, 18.7% year to date, 38.1% over 1 year and a 45.5% return over 3 years, while the 5 year return stands at an 18.1% decline. Recent news coverage on HA Sustainable Infrastructure Capital has...

Recent optimism around Cigna Group (CI) is being shaped by two developments: a policy shift at Evernorth Behavioral Health to remove prior authorization for TMS therapy, and a series of upbeat analyst actions. See our latest analysis for Cigna Group. Against this backdrop, Cigna Group’s share price at US$290.12 comes after a 6.58% 1 month share price return and a 7.61% 3 month share price return. Its 5 year total shareholder return of 47.54% contrasts with a flat 1 year total shareholder...

If you are wondering whether ADMA Biologics is attractively priced at its current level, this article walks through the numbers so you can judge the valuation with more confidence. The stock last closed at US$15.99, with returns of a 1.8% decline over 7 days, a 7.6% decline over 30 days, a 10.6% decline year to date, a 0.5% decline over 1 year, a very large gain over 3 years and a very large gain over 5 years. These mixed shorter term and very strong multi year returns have kept ADMA...

If you are wondering whether Savers Value Village is fairly priced or if the market is missing something, this article will walk you through what the current share price might be implying about its underlying worth. The stock most recently closed at US$10.62, with returns of 1.3% over 30 days, a 12.4% gain year to date, and a 5.2% decline over the past year that may have shifted how investors think about its risk and potential. Recent coverage has focused on Savers Value Village as a...

Trane Technologies (NYSE:TT) has completed its acquisition of Stellar Energy Americas. The deal expands Trane Technologies' offerings in modular and scalable data center cooling solutions. The transaction strengthens the company’s position in energy efficient infrastructure for data centers. Trane Technologies, known for its heating, ventilation and air conditioning solutions, is pushing further into the data center infrastructure space with this acquisition. As data usage grows and more...

As the U.S. stock market kicks off February with a robust performance, highlighted by significant gains in major indices such as the Dow Jones Industrial Average and S&P 500, investors are closely watching the tech sector for potential high-growth opportunities. In this dynamic environment, identifying promising tech stocks involves considering factors like innovation, market demand, and adaptability to current economic conditions.

As February begins, the U.S. stock market has shown notable strength with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting optimism among investors despite ongoing economic uncertainties. In such a vibrant market environment, identifying undervalued stocks can be particularly appealing as they may offer potential for growth at a discounted price.

As February 2026 begins, U.S. stock markets have surged, with major indexes like the Dow Jones and S&P 500 showing strong gains amid positive economic developments such as a new trade deal with India. In this vibrant market environment, growth companies with high insider ownership can offer unique insights into potential success stories, as insiders' vested interests often align closely with shareholder value creation.

As February begins, U.S. stock indexes have shown a strong start with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. While larger market trends capture headlines, investors often overlook smaller opportunities such as penny stocks, which despite their vintage name, continue to offer potential for significant returns when backed by solid financials. This article explores three promising penny stocks that combine balance sheet strength with...

As the U.S. stock market kicks off February with a notable upswing, highlighted by the Dow Jones Industrial Average's 515-point gain and the S&P 500 nearing record highs, investors are keenly observing how economic shifts and policy changes might impact small-cap stocks. Amidst this backdrop of optimism and strategic trade deals, identifying promising opportunities in lesser-known stocks can be an effective strategy for those looking to diversify their portfolios in today's dynamic market...

Twist Bioscience (NasdaqGS:TWST) has entered a co-exclusive licensing agreement for Invenra's bispecific antibody platform. The deal includes an equity stake in Invenra and a seat on Invenra's board of directors. The agreement expands Twist's antibody discovery services into bispecific antibody discovery. For you as an investor, this move extends Twist Bioscience's role beyond DNA synthesis and antibody discovery into a broader bispecific antibody offering, an area that has drawn attention...

If you are wondering whether Exxon Mobil's recent share price puts it on sale or already prices in the story, you are asking the right question before looking at any oil major. The stock last closed at US$150.68, with a 3.1% decline over the past week, a 16.0% return over the last 30 days, 22.9% year to date, 41.3% over 1 year, 52.1% over 3 years, and a very large 5 year return. Recent headlines around Exxon Mobil have focused on its ongoing push within the energy sector and the broader...

GE Vernova (NYSE:GEV) has secured new gas turbine contracts, including a supply deal with Lincoln Electric System in the U.S. The company has also signed a reservation agreement with Maxim Power for a major Canadian gas project. GE Vernova’s Onshore Wind business received U.S. orders to repower over 1 GW of turbines using domestically manufactured components. The combined gas and wind wins expand the company’s role in both conventional power and renewable energy infrastructure. GE Vernova,...

GE Aerospace has agreed to supply 300 GEnx engines to United Airlines for its Boeing 787 Dreamliner fleet. The deal will make United the largest GEnx operator globally once deliveries are complete. The agreement deepens an existing relationship between GE Aerospace and one of the world's biggest airlines. For General Electric (NYSE:GE), this engine order lands against a backdrop of strong recent share performance, with the stock at $329.58 and up 57.5% over the past year. Returns over the...

Mettler-Toledo International has completed a long-running share repurchase program launched in 2010, buying back 17,805,987 shares for US$9.51 billion, including 104,192 shares repurchased for US$143.75 million between October 1 and December 31, 2025. The company’s 2025 results showed year-on-year increases in sales, net income and earnings per share, while management issued 2026 guidance calling for continued local-currency sales growth of about 3% in the first quarter and 4% for the full...

Why SiriusPoint’s latest earnings matter for shareholders SiriusPoint (SPNT) has put fresh financial results on the table, and they are a clear shift from the prior year. For you as a shareholder, the size of that shift is the starting point. See our latest analysis for SiriusPoint. The latest earnings release comes after a 1-year total shareholder return of 46.82% and a very large 3-year total shareholder return of 192.19%. However, the 90-day share price return of 4.15% suggests momentum...

BNCCORP (BNCC) has released its FY 2025 numbers with fourth quarter total revenue of US$9.4 million, basic EPS of US$0.62 and quarterly net income of US$2.2 million, set against a trailing twelve month picture that includes US$38.3 million of revenue and US$2.48 in EPS. Over recent periods the company has seen total revenue move from US$36.3 million to US$38.3 million on a trailing basis, while trailing EPS has shifted from US$2.24 to US$2.48. This gives investors a clearer sense of how the...

Cinemark Holdings (CNK) has put up a mixed FY 2025 scorecard so far, with Q3 revenue of US$857.5 million and EPS of US$0.43, following Q2 revenue of US$940.5 million and EPS of US$0.81, and a Q1 loss of US$0.32 per share on revenue of US$540.7 million. The company has seen revenue move from US$734.2 million in Q2 2024 to US$921.8 million in Q3 2024, alongside EPS shifting from US$0.37 to US$1.54 over that stretch, so investors are likely to focus on how current margins stack up against that...

Harmony Biosciences Holdings (HRMY) is back in focus after the FDA approved a supplemental new drug application for WAKIX, extending its use to treat cataplexy in pediatric narcolepsy patients aged six and older. See our latest analysis for Harmony Biosciences Holdings. Despite the fresh FDA approval, Harmony Biosciences’ share price has been under pressure in the short term, with a 1 day share price return of a 4.44% decline and a 7 day share price return of a 3.58% decline. Its 90 day share...